<DOC>
	<DOC>NCT01015235</DOC>
	<brief_summary>The purpose of this study is to determine whether KAI-1678 is effective in the treatment of postoperative pain following total hip or total knee replacement.</brief_summary>
	<brief_title>Safety and Efficacy Study of KAI-1678 to Treat Subjects With Postoperative Pain</brief_title>
	<detailed_description />
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<criteria>American Society of Anesthesiologist (ASA) classification 1, 2, or 3 total hip or total knee replacement pain on postoperative Day 1 at least 40 mm on 0100 mm visual analog scale (VAS) presence of contraindications to nonsteroidal antiinflammatory (NSAID) treatment recent history of angina or myocardial infarction (MI) clinically significant abnormality on laboratory tests or electrocardiogram (ECG)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Ketorolac / therapeutic use</keyword>
	<keyword>Analgesics. Non-narcotic / therapeutic use</keyword>
	<keyword>Arthroplasty, replacement hip</keyword>
	<keyword>Arthroplasty, replacement knee</keyword>
	<keyword>Pain measurement / drug effect</keyword>
	<keyword>Pain postoperative / drug therapy</keyword>
</DOC>